Top Markets
Coin of the day
RBC Life Sciences, Inc. RBC Life Sciences, Inc.

RBC Life Sciences, Inc.

RBCL
Rank in Stocks #42412
RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional... RBC Life Sciences, Inc. manufactures, markets, and distributes nutritional supplements and personal care products. The company offers wellness products, weight loss, sports, and fitness products. RBC Life Sciences, Inc. is headquartered in Irving, Texas.
Share Price
$0.0007
Last synced: 2026-08-11
Market Cap
$1.55K
Change (1 day)
0.00%
Change (1 year)
600.00%
Country
US
Trade RBC Life Sciences, Inc. (RBCL)
P/E ratio for RBC Life Sciences, Inc. (RBCL)
P/E ratio as of 2026 TTM: 0
According to RBC Life Sciences, Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for RBC Life Sciences, Inc. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
Company P/E Ratio P/E Ratio Difference Country
21.41 -
US
32.48 -
FR
35.89 -
US
33.01 -
IN
- -
DE
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.